Clinical Trial

The Registry of Genetic Expression of Taiwan Urologic Cancer

Name: The Registry of Genetic Expression of Taiwan Urologic Cancer — clinical trial record (NCT05725304)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This project is a nationwide precision medicine program for urothelial carcinoma and renal cell carcinoma.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-02-02; most recent amendment 2025-05-19.

Status change: Recruiting → Active, Not Recruiting 2025-05-19

Trial Details

NCT Number	NCT05725304
Lead Sponsor	National Health Research Institutes, Taiwan Collaborators: Taipei Veterans General Hospital, Taiwan, National Taiwan University Hospital, Tri-Service General Hospital (TSGH), Chang Gung Memorial Hospital, Taichung Veterans General Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions	Urologic Cancer
Enrollment	500 participants
Start Date	2023-01-07
Primary Completion	2029-10-29 (estimated)
Study Completion	2029-10-29 (estimated)
Updated on ClinicalTrials.gov	2025-05-22